Press release
Polycystic Ovarian Syndrome Drugs Global Industry Overview and Competitive Landscape till 2032
According to the latest market report published by Persistence Market Research titled 'Polycystic Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016-2024', the global polycystic syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016-2024 and is expected to expand 1.5x in terms of revenue by 2024. The report analyzes the global PCOS drugs market performance and provides information on key drivers and trends likely to impact the market during the forecast period.Growth of the global polycystic syndrome drugs market is mainly driven by increasing prevalence of the disease and a growing awareness among the patient population. Increasing purchasing power among people and rising awareness of PCOS are factors expected to drive growth of the global PCOS drugs market.
Request For Free Sample Report of "Polycystic Ovarian Syndrome Drugs Market"@ https://www.persistencemarketresearch.com/samples/3682
The need for effective management of diseases associated with PCOS such as hirsutism, obesity, and infertility is likely to boost the demand for PCOS drugs. Also, a growing popularity of combination drugs and their rising adoption among the patient population is expected to boost revenue growth of the PCOS drugs market in the coming years.
A rising expenditure on research and development activities and introduction of novel drugs is further expected to boost growth of the global polycystic syndrome drugs market over the forecast period. However, lack of FDA approved drugs, a low level of awareness of PCOS in underdeveloped countries, and increasing side effects associated with generics might hamper market growth during the forecast period.
The global market for PCOS drugs presents several growth opportunities for market players. There is a good growth potential in emerging markets and pharmaceutical drugs manufacturers are focusing on emerging economies in the Asia Pacific and Africa such as Kenya, Nigeria, etc. to target a large patient population. Also, effective reimbursement policies and reduction in the costs of drugs used for the treatment of PCOS is likely to increase the adoption of PCOS drugs across the globe.
Companies
Novartis AG
Sanofi.
Teva Pharmaceutical Industries Limited
Merck & Co., Inc. (Merck group)
AstraZeneca plc
Bayer AG
Abbott
Pfizer, Inc.
Bristol-Myer Squibb Company
Ferring Pharmaceuticals, Inc.
Johnson and Johnson
Mylan N.V.
Allergan plc.
GlaxoSmithKline
Lupin Pharmaceuticals
AbbVie
Takeda
BIOCAD Global
Blairex Laboratories Inc.
Agile Therapeutics
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/3682
Leading market players are also investing significantly in developing new branded drugs to treat PCOS, owing to an anticipated high rise in the global patient population. The demand for branded PCOS drugs is likely to increase significantly during the forecast period.
The global PCOS drugs market is segmented based on Drug Class into Oral Contraceptives, Insulin Sensitizing Agents, Anti-Depressants, Ornithine Decarboxylase Inhibitors, Aromatase Inhibitors, and Diuretics. The contraceptive drug class segment is projected to register a CAGR of 5.4% over the forecast period.
Oral contraceptives are generally the preferred first line therapy for the treatment of PCOS as they are easily available as OTC drugs. The insulin sensitizing agent segment is expected to register a CAGR of 4.8% over the forecast period. About 70% of PCOS patients are overweight and are in the category of possible candidates for type 2 diabetes.
Key Questions Answered in This Report.
• What are the Roadblocks for Polycystic Ovarian Syndrome Drugs Suppliers?
• What are the Key Opportunities for Polycystic Ovarian Syndrome Drugs Manufacturers?
• How is Focus on Safety Influencing Polycystic Ovarian Syndrome Drugs Demand?
• What is the Regulatory Impact on Global Sales of Polycystic Ovarian Syndrome Drugs?
• Which Region Offers the Largest Opportunity for Sales of Polycystic Ovarian Syndrome Drugs?
• Where Does the U.S. Stand in the Market for Polycystic Ovarian Syndrome Drugs?
• What Is the Outlook for Polycystic Ovarian Syndrome Drugs Manufacturers in China?
• Why is Germany a Lucrative Market for Polycystic Ovarian Syndrome Drugs Manufacturers?
• Why Will Belgium Outpace Other European Markets for Polycystic Ovarian Syndrome Drugs?
• Why is There High Demand for Tires in Polycystic Ovarian Syndrome Drugs?
• Why are Sales of Polycystic Ovarian Syndrome Drugs Surging?
Request Customization @ https://www.persistencemarketresearch.com/request-customization/3682
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Polycystic Ovarian Syndrome Drugs Global Industry Overview and Competitive Landscape till 2032 here
News-ID: 2812538 • Views: …
More Releases from Persistence Market Research
Europe Calf Milk Replacer Market to Reach US$1,657.2 Mn by 2032 | Driven by Risi …
The Europe calf milk replacer market is poised for significant growth over the coming years. The market size is projected to reach US$1,018.6 million in 2025 and is anticipated to expand to US$1,657.2 million by 2032, registering a robust compound annual growth rate (CAGR) of 7.2% during the forecast period from 2025 to 2032. The growth trajectory is driven by the increasing awareness among dairy farmers regarding the nutritional requirements…
Croscarmellose Sodium Market to Reach $487 Mn by 2032, Driven by Rising Pharma D …
The global croscarmellose sodium market is projected to witness significant expansion over the forecast period, reflecting the growing adoption of pharmaceutical excipients across diverse applications. Valued at approximately US$ 288.7 million in 2025, the market is expected to reach US$ 487.0 million by 2032, registering a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032. This growth trajectory is driven primarily by increasing demand for orally disintegrating tablets…
Europe Egg Replacement Ingredients Market to Reach $1,711.1 Mn by 2032, Driven b …
The Europe egg replacement ingredients market is witnessing significant expansion, driven by the increasing adoption of plant-based diets and rising consumer awareness regarding health and wellness. The market size is projected to reach US$ 952.2 million in 2025 and is expected to surge to US$ 1,711.1 million by 2032, registering a robust CAGR of 8.7% over the forecast period from 2025 to 2032. The growing demand for clean-label products, vegan…
Kraft Paper Market to Reach US$ 25.0 Billion by 2032: Growth Driven by Rising De …
The global Kraft Paper market is undergoing significant expansion, driven by the accelerating shift toward eco-friendly packaging materials and the rising global awareness surrounding sustainability. As industries worldwide transition from plastic-based packaging to biodegradable alternatives, kraft paper has emerged as one of the most sought-after materials due to its strength, recyclability, and versatility.
According to the latest study by Persistence Market Research, the global Kraft Paper market size is projected to…
More Releases for PCOS
Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728
Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis…
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this…
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,…
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with…
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy
PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.…
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness.
Get Free Sample Research Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10043
PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms…
